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INTRODUCTION
IGLM is a rare chronic inflammatory disease of the breast 
that mimics cancer both clinically and mammographically [1]. 
The etiology of IGLM is still obscure. The cause may be the 
autoimmune process, infection, a chemical reaction associated 
with oral contraceptive pills, or even lactation. Lymphocyte 
and macrophage migration occurs as a result of ductal epithe-
lium damage, and a local immune response is produced [2,3]. 
The clinical and radiologic features of IGLM are very similar 
to tuberculosis and carcinoma of the breast. The most common 
clinical finding is a unilateral, discrete breast mass. Histopa-
thology generally provides a definitive diagnosis, which is char-
acterized by necrotizing chronic granulomatous lobulitis with 
micro-abscesses [3-6]. The treatment of IGLM remains con-
troversial. Complete surgical excision with or without cortico-
steroids has been suggested in the literature. In some cases, the 
disease recurs in more than half of patients when limited exci-
sion is performed [3,7,8]. Although IGLM is a benign disease, 
repeated surgical interventions lead to poor cosmetic results. 
The main purpose of this study is to present the clinicopath- 
o  logical features of patients with IGLM as well as the authors’ 
experience with medical and surgical treatment of these pa-
tients.  
METHODS
We reviewed hospital records of 19 cases of IGLM histo-
pathologically diagnosed between January 2005 and December 
2010. Their clinical presentation, personal and family history 
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Purpose: Idiopathic granulomatous lobular mastitis (IGLM) is a 
rare chronic inflammatory disease of the breast with obscure eti-
ology that mimics invasive carcinoma both clinically and radi- 
ologically. The treatment of IGLM remains controversial. The aim 
of proper management is to use a combination of medical and 
surgical treatment of this benign condition to achieve a good 
cosmetic result and low recurrence rate. Methods: A retrospec-
tive analysis of 19 patients with IGLM is performed based on the 
findings of clinical, radiological, and pathological examinations. 
The results of two treatments are presented: medical treatment 
with oral corticosteroids, and consecutive surgical excision after 
a follow-up period of 20 months (range, 6-75 months). Results: 
The majority of patients treated in this paper were young (mean, 
34 years) parous women with a history of hormonal medication 
use. The main clinical finding is large, irregular, and painful mass. 
Hypoechoic lobulated, irregular tubular or oval shaped masses 
had been imaged by ultrasound. Mammographic findings were 
an ill-defined mass, enlarged axillary lymph nodes, asymmetric 
density, and architectural distortion. Diagnoses of IGLM had been 
established by cytological or histological examination. Symptoms 
subside and inflammatory changes regressed with medical treat-
ment. The remaining lesions were excised by consecutive breast 
conserving surgery. The disease recurred in one patient during 
the follow-up period. Conclusion: IGLM is an inflammatory breast 
disease found in young women who present with a large painful 
irregular mass, which mimics carcinoma, as a physical change. 
Breast imaging modalities are not helpful to differentiate IGLM 
from invasive cancer. The correct diagnosis is established by   
cytological or histological examination. Medical treatment with 
corticosteroids provides significant regression of the inflamma-
tory disease, allowing more conservative surgery. Consecutive 
surgical excision of the remaining lesions with good cosmetic   
results provides definitive treatment and reduces the risk of           
recurrence. 
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were recorded, as were findings from physical examination of 
the breast. An ultrasound was carried out on all patients. A 
mammogram was obtained from patients older than 35 years. 
An magnetic resonance imaging (MRI) was used in three cases. 
Pathological diagnosis was established after fine needle aspira-
tion cytology (FNAC), core biopsy or incisional biopsy. Inci-
sional biopsies from the abscess wall were performed on three 
patients who presented with abscess drainage. All aspirates and 
tissue samples were stained with the Papanicolaou staining 
procedure (PAP) as well as special stains for tuberculosis and 
fungal infection. No micro-organisms were found via micro-
biologic testing of aspirate and/or tissue samples. In all cases, 
stains for acid-fast bacilli and fungus were negative in sections 
of cell blocks and tissue.
The initial prescription given to patients was oral methyl-
prednisolone 0.8 mg/kg/day in the first week. The medical treat-
ment was completed in 8 weeks, reducing the weekly cortico-
steroid dose by 0.1 mg/kg. At the end of the eighth week, pa-
tients were clinically and radiologically evaluated for regres-
sion of breast and skin lesions. For all patients, local excision 
was performed for remnant lesions in the 2 weeks following 
the evaluation of medical treatment results. 
RESULTS
The mean age of patients is 34.1 years (range, 27-59 years). 
Most of the patients (14/19) are at a reproductive age. All pa-
tients have children. Eight patients (42%) have a history of oral 
contraceptive use. Fifteen (79%) patients have a history of lacta-
tion, and four were lactating in the last 6 months. None of the 
patients have a family history of breast cancer. The left breast 
is seen to be affected in 10 patients. Upon admission, the most 
common symptom, occurring in 15 patients, is a palpable mass 
of 2.5 to 9 cm (Table 1). Three patients present with ulcerative 
skin lesions (Figure 1).
Ultrasonography of the breast establishes a hipoechoic lobul- 
ated, irregular tubular or oval shaped mass in 13 patients (Table 
2). Mammographic examination of the breast is performed in 
13 patients. The major radiographic finding is an ill defined 
mass, occurring in six patients (Figure 2). Mammography   
Table 1. Symptoms and signs in patients with IGLM
Symptoms and signs No. (%)
Palpable mass 15 (79)
Painful swelling 6 (31.6)
Abscess 3 (15.8)
Ulcerative skin lesions 3 (15.8)
Sinus formation 3 (15.8)
Nipple retraction 1 (5.3)
Axillary lymphadenopathy 2 (10.5)
IGLM=idiopathic granulomatous lobular mastitis.
Table 2. Ultrasonography and mammography findings in patients with 
IGLM
Imaging modality No. (%)
Ultrasonography (n=19)
   Hypoechoic lobulated mass 7 (36.8)
   Irregular tubular mass and parenchymal distortion 4 (21)
   Parenchymal mixed echogenicity and skin thickening 3 (15.8)
   Abscess collection and fistula tract 3 (15.8)
   Oval shaped mass 2 (10.5) 
Mammography (n=13)
   Ill-defined mass    6 (46)
   Enlarged axillary lymph nodes 5 (38.5)
   Asymmetric density 4 (30.8)
   Architectural distortion 3 (23)
IGLM=idiopathic granulomatous lobular mastitis.
Figure 1. Skin lesions of a patient with idiopathic granulomatous lobular 
mastitis. Clinical presentation may mimic locally advanced breast carci-
noma.
Figure 2. Mammo-
graphic finding (cranio-
caudal view). It shows 
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detects enlarged axillary lymph nodes in five patients. Three 
patients are subjected to an MRI, which shows a heterogeneous 
mass with an irregular border in two, and a parenchymal dis-
tortion in the other (Figure 3).
For three patients, a histopathological evaluation is performed 
with incisional biopsy from the abscess wall during the surgi-
cal drainage. An FNAC or core biopsy is performed for the 
remaining 16 patients. The FNA material is seen to contain 
chronic inflammation of the plasma cells, neutrophilic infiltra-
tion, non-caseating granulomas, and multinuclear giant cells 
(Figure 4). The major pathological changes in histological sec-
tions are found to be a granulomatous inflammatory reaction 
centered on the lobules. Granulomas composed of epitheloid 
histiocytes, langhans giant cells accompanied by lymphocytes, 
and plasma cells are generally found within and around dilated 
lobules (Figure 5).  
Despite highly significant regression of inflammatory changes, 
Figure 6. Gross finding after medical treament. The skin lesions regressed 
markedly.
Figure 4. Fine needle aspiration cytology finding. It shows a huge gran-
uloma formation, with chronic inflammatory cells in the background (PAP, 
×100 [Inlet magnification is ×200]).
Figure 3. Magnetic resonance imaging. It shows a heterogeneous mass. 
Figure 5. Microscopic finding of operative specimen. It shows dilated 
intermediary-sized ducts with a surrounding inflammatory infiltrate of 
lymphocytes, plasma cells, and granuloma formation (H&E stain, ×100 
[Inlet magnification is ×200]).
Figure 7. Operation wounds after excision of remaining lesions. It shows 
good cosmetic results.122  GunayGurleyik,etal.
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none of the patients display a complete clinical response to 
steroid treatment (Figure 6). After steroid treatment, local     
excisions of the remaining lesions are performed with good 
cosmetic results in all patients (Figure 7). The median follow-
up period is 20 months (range, 6-75 months). During the fol-
low-up period, recurrence was observed in one patient. Recur-
rent lesions were treated with surgical re-excision.  
DISCUSSION
IGLM is a rare chronic non-specific inflammatory lesion of 
the breast that can clinically mimic breast cancer. Originally 
described by Kessler and Wolloch in 1972, it is characterized 
by the presence of epitheloid and multinucleated giant cell 
granulomas limited to the mammary lobules with micro-               
abscesses in the absence of obvious etiology [9]. Local or system-
ic irritants as well as undetected infective causes may result in 
damage to the ductal epithelium. Luminal fat and protein rich 
secretion into the lobular connective tissue produces a localized 
granulomatous response [2,5]. This association has recently 
been challenged, because serologic and bacterial tests are usu-
ally negative in patients presenting with IGLM. 
Based on our findings, it can be deduced that a recent history 
of pregnancy, lactation, and use of oral contraceptive play are 
factors that play an important role in the etiology of IGLM. 
Other authors have also suggested that the prior use of oral 
contraceptive, a history of breast feeding, and pregnancy are 
linked to IGLM. High levels of serum prolactin as well as dis-
tention of the acini and ducts may result in a rupture of these 
structures, inducing a granulomatous response [8-10]. There-
fore, this history should be carefully evaluated in young wom-
en with a painful breast mass, and IGLM must be taken into 
account in when performing a diagnosis. In the present study, 
the mean age of the patients is 34.1 years (range, 27-59 years). 
Parous and young women are the most likely to contract IGLM. 
Despite the fact that the youngest patient reported in the litera- 
ture is eleven years old, age at presentation is generally between 
20 and 50 years [6-9]. In general, IGLM can be considered a 
disease of women at a reproductive age.
The most common clinical sign in patients at first admission 
is found to be a unilateral painful breast mass. Similarly, the 
most common presentation in previous studies was also a breast 
mass and pain [2-6]. This symptom of a breast mass easily mimics 
a malignant mass, which has a dramatic effect on differential 
diagnosis. Skin lesions and enlarged axillary lymph nodes are 
other suspicious signs of malignancy identified in this paper. 
In other recent papers on IGLM, authors have reported the pres-
ence of inflammation, swelling of the breast skin, and axillary 
lymphadenopathy as well as skin ulceration and fistula [2-6].
Ultrasound and mammography identify an irregular and   
ill defined mass in the majority of patients. The information, 
obtained from imaging techniques, is non-specific when it 
comes to diagnosis of IGLM. For this reason, the role of radi- 
ological imaging is limited in differentiating IGLM from other 
inflammatory and malignant conditions. Ultrasound findings 
are variable. Memis et al. [11] report that frequent sonographic 
features of IGLM are irregular hypoechoic mass lesions and 
tubular hypoechoic areas connecting to the mass. In other 
works, parenchymal heterogeneity and areas of mixed echo 
pattern with parenchymal deformity have been described in 
addition to the irregular hypoechoic mass lesion [4,7]. In the 
present work, ultrasound images of lobulated and tubular masses 
with parenchymal distortion are not disease specific. These 
images can lead to a misdiagnosis of malignant changes. How-
ever, ultrasound images of multiple abscess collections in add- 
ition to structural changes and a breast mass may indicate the 
presence of an inflammatory granulomatous process.  
An ill defined mass with asymmetric diffuse density and skin 
thickening are the most common mammographic findings 
[4,11]. For patients in this study, an irregular mass and asym-
metric density is non-specific mammographic findings, as they 
could be symptoms of various breast diseases. As well as these 
lesions, enlarged axillary lymph nodes, which are detected in 
five patients in this study, give the impression of a regional spread 
of breast malignancy. MRI is used for three patients but does 
not provide critical information for correct diagnosis. Other 
studies have also used MRI and found that it does not provide 
additional information for the differentiation of mastitis from 
carcinoma [4,6]. This process has high sensitivity, but low speci- 
ficity for most breast lesions. 
In this study, we found that clinical and radiological findings 
are insufficient for diagnosis of IGLM as they are not disease 
specific. Lesions identified clinically and radiologically could 
easily be misdiagnosed as carcinoma. Therefore, histopath- 
ological evaluation plays a very important role in differentiating 
these lesions from other granulomatous conditions, inflam-
matory changes, and carcinoma. Diagnosis of IGLM is estab-
lished through the use of FNAC in the majority of patients in 
this study, while core and incisional biopsy is used to the rest. 
This result is confirmed by examination of removed tissue at 
the end of the medical treatment. A definitive diagnosis of 
IGLM can be made by FNAC, core biopsy or incisional and 
excisional biopsy [2,5,12]. The histopathological features of 
IGLM are non-caseating granuloma, composed of epitheloid 
histiocytes with giant cells within and around the lobules.
There is still no accepted management strategy for IGLM. 
Oral corticosteroids and surgery have both been used as treat-
ment options. Limited excision alone has little benefit as there TreatmentofIdiopathicGranulomatousMastitis 123
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is a strong tendency of recurrence. However, initial excision of 
breast tissue ensures negative margins for inflammatory gran-
ulamatous tissue, but may have unfavorable cosmetic results.   
Oral corticosteroids have most often been used in recurrent 
cases in previous studies [7-10,13]. Initial medical treatment in 
the present study also takes the form of oral steroids. Proper 
treatment is evident by the regression of skin lesions and paren-
chymal enduration in nearly all patients at the end of the eighth 
week. In order to decrease the rate of relapse, surgical excision 
of the remaining lesions is carried out in the 2 weeks following 
the end of medical treatment. The initial use of a course of oral 
steroids provides important regression of breast mass and skin 
lesions, allowing more limited surgery. This may prevent repeti- 
tive deforming operations and recurrences. The recurrence 
rate has been reported as 16-50% in the literature [3,7]. In our 
follow-up period, IGLM is seen to recur in only one patient, 
on the sixth month, resulting in a need for re-excision.
IGLM is a chronic inflammatory breast disease found in 
young women of reproductive age. The use of hormonal treat-
ments in the patient’s past is found to play a role in the etiology 
of inflammatory change. A painful, irregular mass is a com-
mon physical finding. This irregular breast mass mimics car-
cinoma. When faced with this clinical picture, the most impor-
tant step of diagnosis is to remember the possibility of IGLM 
as a cause. Awareness of IGLM in young women with painful 
breast mass leads to a more accurate diagnosis by medical prac-
titioners. Radiological examinations do not result in specific 
findings able to differentiate this inflammatory condition from 
invasive carcinoma. However, imaging of multiple micro-abscess 
collections via ultrasound can reveal the presence of an inflam-
matory process. Cytological or histological examination estab-
lishes the correct diagnosis. Medical treatment with cortico-
steroids provides significant regression of the inflammatory 
disease, allowing more conservative surgery. Consecutive sur-
gical excision of the remaining lesions provides definitive treat-
ment and reduces the risk of recurrence. Thanks to regression 
of the inflammatory lesions through the use of oral corticoste-
roids and the evaluation of the conservative approach, good 
cosmetic results and low recurrence rates can be achieved for 
IGLM patients.
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